D-0987-2018 Class II Ongoing

Recalled by Teva Pharmaceuticals USA — North Wales, PA

Recall Details

Product Type
Drugs
Report Date
August 1, 2018
Initiation Date
July 16, 2018
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
30,793 90-count bottles, 1,158 1000-count bottles

Product Description

Valsartan Tablets, USP 80 mg, 90-count bottle (NDC 0591-2168-19), 1000-count bottle (NDC 0591-2168-10), Rx Only, Rx Only, Manufactured by: Arrow Pharma (Malta) Ltd. India, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054

Reason for Recall

CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Distribution Pattern

Product was distributed throughout the United States, including Hawaii and Puerto Rico

Code Information

Lot Numbers: NDC 0591-2168-19 1175947M, 1175948M, 1177115A, 1219361A, 1240434M, 1250704M NDC 0591-2168-10 1177114A, 1219360M, 1250706A